Alireza Kashefizadeh

Statistics

Publications

Citations

747

H-Index

Active since

2020

Affiliations

Shahid Beheshti University of Medical Sciences(Current)

Masih Daneshvari Hospital

Centro de Investigación Biomédica en Red de Enfermedades Respiratorias

Imam Khomeini Hospital

Aalborg University

Alireza Kashefizadeh is an author at Shahid Beheshti University of Medical Sciences specializing in anticoagulant therapy, primary efficacy endpoints, and antithrombotic therapy.

ORCID

Publications per year

2020–2021

Publications

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit

Saeideh Mazloomzadeh, Shiva Khaleghparast, Behshid Ghadrdoost et al. · JAMA · 2021 · 653 citations · Full text

Pharmacy, Pharmacotherapy, Critical Care Pharmacology +16

Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial

Behnood Bikdeli, Azita H. Talasaz, Farid Rashidi et al. · Thrombosis and Haemostasis · 2021 · 79 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Clinical features and short-term outcomes of COVID-19 in Tehran, Iran: An analysis of mortality and hospital stay.

Alireza Kashefizadeh, Laya Ohadi, Maryam Golmohammadi et al. · PubMed · 2020 · 15 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +8

1–3 of 3